Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity represents a **natural antisense transcript (NAT)** transcribed from the DNA strand opposite to the UNC5A (Unc-5 netrin receptor A) gene. NATs are a well-documented component of eukaryotic transcriptomes and exert various regulatory influences on their sense counterparts. Ribosome association and protein-coding potential are generally lacking for such NATs; instead, they commonly affect sense gene expression post-transcriptionally or transcriptionally[3][4]. Specifically, NATs can modulate chromatin architecture, alter transcript stability, suppress or enhance translation, or modify pre-mRNA splicing patterns of target genes[3][1][4]. In the case of this transcript, its function would be presumed to regulate UNC5A expression—possibly influencing neuronal development or cellular apoptosis, given the known roles of UNC5A[2]—but there is currently no experimental evidence that validates a direct biological effect or a disease association for this specific antisense transcript. There are no approved drugs or clinical development programs targeting it, and it is not established as a therapeutic target. Note: - *ENSG00000294630 does not represent a protein-coding gene or classical "therapeutic target" but is rather an annotated non-coding antisense RNA.* - *UNC5A, the gene to which it is antisense, encodes a netrin receptor involved in axon guidance and apoptosis, but this antisense transcript is not equivalent to UNC5A itself[2].* - *Such transcripts are abundant in the genome and mostly remain functionally uncharacterized, though their regulatory functions are increasingly recognized.*
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to UNC5A (null).